Skip to content

News

Press Release
Sep 15, 2022

Aetion joins the GetReal Institute

UTRECHT, THE NETHERLANDS, September 15, 2022 — Following the GetReal Institute’s founding ...
Start Reading
Press Release
Sep 13, 2022

Replica Analytics publishes comprehensive Cardinal Methodology for measuring and managing identity disclosure risks of datasets

OTTAWA, September 14, 2022 — A new book being published by Replica Analytics, an Aetion ...
Start Reading
Press Release
Aug 4, 2022

Evio & Aetion Partner to Deliver Real-World Evidence (RWE) Across the Pharmacy Value Chain

DENVER, CO AND NEW Y ORK, NY (August 4, 2022) — Evio , an independent pharmacy solutions ...
Start Reading
Press Release
Jul 29, 2022

Aetion Named to Best Companies for Women to Advance List from Parity.Org

NEW YORK, NY – July 29, 2022 – Aetion , a leading real-world evidence (RWE) analytics ...
Start Reading
News
Jul 25, 2022

Health equity should start at birth

Medcitynews in 2022 reports that pregnant women and others able to give birth are ...
Start Reading
Press Release
Jul 22, 2022

Aetion Welcomes Chief Product Officer

Aetion is pleased to announce the appointment of Priya Bhargava as Chief Product Officer. ...
Start Reading
Press Release
Jul 19, 2022

Replica Analytics’ new estimator uses synthetic data for more reliable evaluation of re-identification risk in datasets

OTTAWA, July 19, 2022 — Replica Analytics, an Aetion company, has unveiled a novel ...
Start Reading
Press Release
Jun 27, 2022

C-Path and Replica Analytics Collaboration Aims to Accelerate Rare Disease Research

NEW YORK, OTTAWA and TUCSON, Ariz., June 29, 2022 — Critical Path Institute (C-Path) and ...
Start Reading
Press Release
May 5, 2022

EY Announces Carolyn Magill and Dr. Jeremy Rassen of Aetion as Entrepreneur Of The Year® 2022 New York Award Finalists

NEW YORK, NEW YORK | Ernst & Young LLP (EY US) today announced that CEO and Board ...
Start Reading
Press Release
Apr 21, 2022

National Evaluation System for health Technology Coordinating Center (NESTcc) Partners with Aetion to Transform the Role of RWE for Medical Devices

ARLINGTON, Va. and NEW YORK, April 21, 2022 /PRNewswire/ -- Today, the National ...
Start Reading
Press Release
Mar 8, 2022

Cognito Therapeutics and Aetion announce partnership to use artificial intelligence to identify rapidly progressing forms of mild cognitive impairment and Alzheimer's disease

CAMBRIDGE, Mass. & NEW YORK--( BUSINESS WIRE)-- Cognito Therapeutics, a pioneer in ...
Start Reading
News
Feb 7, 2022

Using real-world evidence to advance COVID-19 medical countermeasures

The project focuses on rapidly assessing the safety and effectiveness of COVID-19 ...
Start Reading
News
Jan 4, 2022

Aetion acquires Replica Analytics to bring aboard synthetic data capabilities

Health analytics firm Aetion has acquired Replica Analytics, a company that specializes ...
Start Reading
News
Jan 4, 2022

Real-world evidence firm Aetion grabs privacy-protected synthetic data provider Replica Analytics

Aetion, which provides real-world evidence and analytics to drug companies, payers, life ...
Start Reading
News
Jan 4, 2022

Aetion snaps up AI health data specialist Replica Analytics

Aetion's acquisition of artificial intelligence data specialist Replica Analytics gives ...
Start Reading
News
Jan 4, 2022

Aetion acquires synthetic data platform Replica Analytics

This acquisition allows Aetion to solve for one of the toughest problems in RWE: access ...
Start Reading
News
Jan 4, 2022

Aetion snaps up synthetic real-world data company Replica Analytics

Less than a year after Aetion landed $110 Million in Series C funding, Aetion acquires ...
Start Reading
Press Release
Jan 4, 2022

Aetion acquires synthetic data trailblazer Replica Analytics

NEW YORK, NY and OTTAWA, ON, January 4, 2022 — Aetion, the leading regulatory-grade ...
Start Reading
Press Release
Jan 4, 2022

Replica Analytics Acquired by Aetion

Today, Replica Analytics announced that it had been acquired by healthcare analytics ...
Start Reading
Press Release
Dec 1, 2021

European Medicines Agency selects Aetion to support safety and efficacy research in Europe

BARCELONA, SPAIN, December 1, 2021 — The European Medicines Agency (EMA) has selected ...
Start Reading
News
Oct 26, 2021

FDA, Aetion expand RWE work to focus on inpatient COVID-19 therapies

FDA and Aetion announced they will use the Aetion Evidence Platform® to gather real-world ...
Start Reading
News
Oct 21, 2021

How to collect and submit RWD to win approval for a new drug indication: FDA spells it out in a long-awaited guidance

EndPoints News reports in 2021 that real-world data are messy. There can be differences ...
Start Reading
News
Oct 21, 2021

FDA contracts Aetion’s real-world evidence platform to assess COVID-19 treatments

The Food and Drug Administration has contracted with real-world evidence company Aetion ...
Start Reading
News
Oct 21, 2021

Real-world evidence: 'Labor-intensive' data standardization may be required by US FDA

New draft guidance offers recommendations for translating real-world data from claims or ...
Start Reading